Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity

Molecular Metabolism

Volumn 2, Issue 4, 2013, Pages 423-434

  Opland, Darren ^a   Sutton, Amy ^b   Woodworth, Hillary ^c   Brown, Juliette ^c   Bugescu, Raluca ^c   Garcia, Adriana ^b   Christensen, Lyndsay ^b   Rhodes, Christopher ^d   Myers, Martin ^b   Leinninger, Gina ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Dopamine; Neurotensin; Obesity; Orexin

Indexed keywords

LEPTIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; FEEDING BEHAVIOR; FOOD PREFERENCE; LIPID DIET; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SUGAR INTAKE; UPREGULATION; VENTRAL TEGMENTUM; WILD TYPE;

ANIMALIA; MUS;

EID: 84889087755     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.07.008     Document Type: Article

References (74)

1. Morrison S.D., Barrnett R.J., Mayer J. Localization of lesions in the lateral hypothalamus of rats with induced adipsia and aphagia. American Journal of Physiology 1958, 193:230-234.
2. Saper C.B., Swanson L.W., Cowan W.M. An autoradiographic study of the efferent connections of the lateral hypothalamic area in the rat. Journal of Comparative Neurology 1979, 183:689-706.
3. Kenny P.J. Reward mechanisms in obesity: new insights and future directions. Neuron 2011, 69:664-679.
4. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003, 144:1506-1512.
5. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
6. Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolanos C.A., Marsh D.J., Bednarek M.A., Bibb J.A., Maratos-Flier E., Nestler E.J., DiLeone R.J. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. Journal of Neuroscience 2005, 25:2933-2940.
7. Watts A.G., Sanchez-Watts G., Kelly A.B. Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia. Journal of Neuroscience 1999, 19:6111-6121.
8. Leinninger G.M., Jo Y.H., Leshan R.L., Louis G.W., Yang H., Barrera J.G., Wilson H., Opland D.M., Faouzi M.A., Gong Y., Jones J.C., Rhodes C.J., Chua S., Diano S., Horvath T.L., Seeley R.J., Becker J.B., Munzberg H., Myers M.G. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metabolism 2009, 10:89-98.
9. Leinninger G.M., Opland D.M., Jo Y.H., Faouzi M., Christensen L., Cappellucci L.A., Rhodes C.J., Gnegy M.E., Becker J.B., Pothos E.N., Seasholtz A.F., Thompson R.C., Myers M.G. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metabolism 2011, 14:313-323.
10. Kempadoo K.A., Tourino C., Cho S.L., Magnani F., Leinninger G.M., Stuber G.D., Zhang F., Myers M.G., Deisseroth K., de Lecea L., Bonci A. Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. Journal of Neuroscience 2013, 33:7618-7626.
11. Legault M., Congar P., Michel F.J., Trudeau L.E. Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones. Neuroscience 2002, 111:177-187.
12. Sotty F., Souliere F., Brun P., Chouvet G., Steinberg R., Soubrie P., Renaud B., Suaud-Chagny M.F. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. Neuroscience 1998, 85:1173-1182.
13. St-Gelais F., Legault M., Bourque M.J., Rompre P.P., Trudeau L.E. Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons. Journal of Neuroscience 2004, 24:2566-2574.
14. Kalivas P.W., Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. Journal of Neuroscience 1990, 10:2940-2949.
15. Sotty F., Brun P., Leonetti M., Steinberg R., Soubrie P., Renaud B., Suaud-Chagny M.F. Comparative effects of neurotensin, neurotensin(8-13) and [d-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens. Neuroscience 2000, 98:485-492.
16. Kim E.R., Leckstrom A., Mizuno T.M. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice. Behavioural Brain Research 2008, 194:66-71.
17. Kim E.R., Mizuno T.M. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides. Neuroscience Letters 2010, 468:64-67.
18. Luttinger D., King R.A., Sheppard D., Strupp J., Nemeroff C.B., Prange A.J. The effect of neurotensin on food consumption in the rat. European Journal of Pharmacology 1982, 81:499-503.
19. Boules M., McMahon B., Warrington L., Stewart J., Jackson J., Fauq A., McCormick D., Richelson E. Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. Brain Research 2001, 919:1-11.
20. Ervin G.N., Birkemo L.S., Nemeroff C.B., Prange A.J. Neurotensin blocks certain amphetamine-induced behaviours. Nature 1981, 291:73-76.
21. Steinberg R., Brun P., Fournier M., Souilhac J., Rodier D., Mons G., Terranova J.P., Le Fur G., Soubrie P. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 1994, 59:921-929.
22. Elliott P.J., Nemeroff C.B. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and d-amphetamine-induced locomotor activity. Neuroscience Letters 1986, 68:239-244.
23. Feifel D., Reza T.L. Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle. Behavioural Brain Research 1999, 106:189-193.
24. Kalivas P.W., Burgess S.K., Nemeroff C.B., Prange A.J. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 1983, 8:495-505.
25. Cador M., Kelley A.E., Le Moal M., Stinus L. Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berlin) 1985, 85:187-196.
26. Hawkins M.F., Baker J.D., Baumeister A.A. Neurotensin-induced polydipsia: a structure-activity study. Brain Research 1989, 487:188-191.
27. Geisler S., Berod A., Zahm D.S., Rostene W. Brain neurotensin, psychostimulants, and stress-emphasis on neuroanatomical substrates. Peptides 2006, 27:2364-2384.
28. Boules M., Johnston H., Tozy J., Smith K., Li Z., Richelson E. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine. Behavioral Pharmacology 2011, 22:573-581.
29. Maeno H., Yamada K., Santo-Yamada Y., Aoki K., Sun Y.J., Sato E., Fukushima T., Ogura H., Araki T., Kamichi S., Kimura I., Yamano M., Maeno-Hikichi Y., Watase K., Aoki S., Kiyama H., Wada E., Wada K. Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Brain Research 2004, 998:122-129.
30. Smith K.E., Boules M., Williams K., Fauq A.H., Richelson E. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia. Behavioural Brain Research 2011, 224:344-349.
31. Sclafani A. Enhanced sucrose and Polycose preference in sweet sensitive (C57BL/6J) and subsensitive (129P3/J) mice after experience with these saccharides. Physiology and Behavior 2006, 87:745-756.
32. Leshan R.L., Louis G.W., Jo Y.H., Rhodes C.J., Munzberg H., Myers M.G. Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus. Journal of Neuroscience 2009, 29:3138-3147.
33. Paxinos, G., Franklin, B., 2001. The Mouse Brain in Stereotaxic Coordinates. Second edn., (Academic Press, 2001).
34. Boules M., Iversen I., Oliveros A., Shaw A., Williams K., Robinson J., Fredrickson P., Richelson E. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Brain Research 2007, 1127:90-98.
35. Panayi F., Colussi-Mas J., Lambas-Senas L., Renaud B., Scarna H., Berod A. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization. Neuropsychopharmacology 2005, 30:871-879.
36. Kalivas P.W., Taylor S. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Research 1985, 358:70-76.
37. Leinninger G.M. Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. Physiology and Behavior 2011, 104:572-581.
38. Meyer M.P., Smith S.J. Evidence from in vivo imaging that synaptogenesis guides the growth and branching of axonal arbors by two distinct mechanisms. Journal of Neuroscience 2006, 26:3604-3614.
39. Kahn D., Abrams G.M., Zimmerman E.A., Carraway R., Leeman S.E. Neurotensin neurons in the rat hypothalamus: an immunocytochemical study. Endocrinology 1980, 107:47-54.
40. Seutin V., Massotte L., Dresse A. Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology 1989, 28:949-954.
41. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., Flier J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
42. Beck B., Stricker-Krongrad A., Richy S., Burlet C. Evidence that hypothalamic neurotensin signals leptin effects on feeding behavior in normal and fat-preferring rats. Biochemical and Biophysical Research Communications 1998, 252:634-638.
43. Hawkins M.F. Central nervous system neurotensin and feeding. Physiology and Behavior 1986, 36:1-8.
44. Sahu A., Carraway R.E., Wang Y.P. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Brain Research 2001, 888:343-347.
45. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., Chou J., Chen B.T., Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. Journal of Neuroscience 2009, 29:11215-11225.
46. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
47. Felszeghy K., Espinosa J.M., Scarna H., Berod A., Rostene W., Pelaprat D. Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference. Neuropsychopharmacology 2007, 32:2601-2610.
48. Glimcher P.W., Giovino A.A., Hoebel B.G. Neurotensin self-injection in the ventral tegmental area. Brain Research 1987, 403:147-150.
49. Glimcher P.W., Margolin D.H., Giovino A.A., Hoebel B.G. Neurotensin: a new 'reward peptide'. Brain Research 1984, 291:119-124.
50. Boules M., Oliveros A., Liang Y., Williams K., Shaw A., Robinson J., Fredrickson P., Richelson E. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats. Neuropeptides 2011, 45:9-16.
51. Li Z., Boules M., Richelson E. NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse. Neuroscience Letters 2011, 487:322-324.
52. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
53. Boudin H., Pelaprat D., Rostene W., Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. Journal of Comparative Neurology 1996, 373:76-89.
54. Goedert M., Pittaway K., Williams B.J., Emson P.C. Specific binding of tritiated neurotensin to rat brain membranes: characterization and regional distribution. Brain Research 1984, 304:71-81.
55. Young W.S., Kuhar M.J. Neurotensin receptor localization by light microscopic autoradiography in rat brain. Brain Research 1981, 206:273-285.
56. Birgner C., Nordenankar K., Lundblad M., Mendez J.A., Smith C., le Greves M., Galter D., Olson L., Fredriksson A., Trudeau L.E., Kullander K., Wallen-Mackenzie A. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proceedings of the National Academy of Sciences of United States of America 2010, 107:389-394.
57. Sulzer D., Joyce M.P., Lin L., Geldwert D., Haber S.N., Hattori T., Rayport S. Dopamine neurons make glutamatergic synapses in vitro. Journal of Neuroscience 1998, 18:4588-4602.
58. Hao J., Cabeza de Vaca S., Carr K.D. Effects of chronic ICV leptin infusion on motor-activating effects of d-amphetamine in food-restricted and ad libitum fed rats. Physiology and Behavior 2004, 83:377-381.
59. Shalev U., Yap J., Shaham Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. Journal of Neuroscience 2001, 21:RC129.
60. Leonetti M., Brun P., Clerget M., Steinberg R., Soubrie P., Renaud B., Suaud-Chagny M.F. Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice. Journal of Neurochemistry 2004, 89:1-6.
61. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. Journal of Pharmacology and Experimental Therapeutics 2002, 300:305-313.
62. Azzi M., Betancur C., Sillaber I., Spanagel R., Rostene W., Berod A. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems. Journal of Neurochemistry 1998, 71:1158-1167.
63. Azzi M., Nicot A., Gully D., Kitabgi P., Berod A., Rostene W. Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692. Neuroscience Letters 1994, 172:97-100.
64. Najimi M., Robert J.J., Mallet J., Rostene W., Forgez P. Neurotensin induces tyrosine hydroxylase gene activation through nitric oxide and protein kinase C signaling pathways. Molecular Pharmacology 2002, 62:647-653.
65. Liang Y., Boules M., Li Z., Williams K., Miura T., Oliveros A., Richelson E. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology 2010, 58:1199-1205.
66. Grill H.J. Leptin and the systems neuroscience of meal size control. Frontiers inNeuroendocrinology 2010, 31:61-78.
67. Kortleven C., Bruneau L.C., Trudeau L.E. Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. Neuropharmacology 2012, 63:983-991.
68. Sarret P., Beaudet A., Vincent J.P., Mazella J. Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain. Journal of Comparative Neurology 1998, 394:344-356.
69. Nouel D., Faure M.P., Pierre J.A., Alonso R., Quirion R., Beaudet A. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. Journal of Neuroscience 1997, 17:1795-1803.
70. Yamauchi R., Wada E., Kamichi S., Yamada D., Maeno H., Delawary M., Nakazawa T., Yamamoto T., Wada K. Neurotensin type 2 receptor is involved in fear memory in mice. Journal of Neurochemistry 2007, 102:1669-1676.
71. Furutani N., Hondo M., Kageyama H., Tsujino N., Mieda M., Yanagisawa M., Shioda S., Sakurai T. Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness States. PLoS One 2013, 8:e62391.
72. Alexiou C., Zimmermann J.P., Schick R.R., Schusdziarra V. Xenin-a novel suppressor of food intake in rats. Brain Research 1998, 800:294-299.
73. Hawkins M.F., Barkemeyer C.A., Tulley R.T. Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding. Pharmacology, Biochemistry and Behavior 1986, 24:1195-1201.
74. Laque A., Zhang Y., Gettys S., Nguyen T.A., Bui K., Morrison C.D., Muenzberg-Gruening H. Leptin receptor neurons in the mouse hypothalamus are co-localized with the neuropeptide galanin and mediate anorexigenic leptin action. American Journal of Physiology-Endocrinologyand Metabolism 2013.